{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System - GN Ceftazidime/avibactam"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K163637",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121546"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "December 21, 2016",
    "Summary Letter Received Date": "December 23, 2016",
    "Submission Date": "December 21, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftazidime/avibactam susceptibility",
        "Citrobacter freundii complex",
        "Citrobacter koseri",
        "Escherichia coli",
        "Enterobacter aerogenes",
        "Enterobacter cloacae",
        "Klebsiella pneumoniae",
        "Klebsiella oxytoca",
        "Proteus spp.",
        "Pseudomonas aeruginosa",
        "Morganella morganii",
        "Providencia stuartii",
        "Serratia marcescens"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument",
        "BD Phoenix AP System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth-based microdilution",
        "Automated susceptibility testing",
        "Redox indicator growth detection"
    ],
    "Methodologies": [
        "Minimal inhibitory concentration (MIC) determination",
        "Antimicrobial susceptibility testing (AST)",
        "Rapid identification (ID)"
    ],
    "Submission Type(s)": [
        "System",
        "Instrument",
        "Panel",
        "Software",
        "Broth",
        "Indicator solution"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System - GN Ceftazidime/avibactam for automated antimicrobial susceptibility testing of Gram-negative bacterial isolates",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC of most Gram-negative aerobic and facultative anaerobic bacteria isolates from pure culture for Enterobacteriaceae and Non-Enterobacteriaceae, and most Gram-positive isolates from Staphylococcus, Enterococcus, and Streptococcus genera",
    "fda_folder": "Microbiology"
}